Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 23

Related Articles by Review for PubMed (Select 18254653)

1.

Prevention of rectal SHIV transmission in macaques by daily or intermittent prophylaxis with emtricitabine and tenofovir.

García-Lerma JG, Otten RA, Qari SH, Jackson E, Cong ME, Masciotra S, Luo W, Kim C, Adams DR, Monsour M, Lipscomb J, Johnson JA, Delinsky D, Schinazi RF, Janssen R, Folks TM, Heneine W.

PLoS Med. 2008 Feb;5(2):e28. doi: 10.1371/journal.pmed.0050028.

2.

Antiretroviral pre-exposure prophylaxis (PrEP) for preventing HIV in high-risk individuals.

Okwundu CI, Uthman OA, Okoromah CA.

Cochrane Database Syst Rev. 2012 Jul 11;7:CD007189. doi: 10.1002/14651858.CD007189.pub3. Review.

PMID:
22786505
3.

Considerations regarding antiretroviral chemoprophylaxis in MSM.

Poynten IM, Zablotska I, Grulich AE.

Curr Opin HIV AIDS. 2012 Nov;7(6):549-56. doi: 10.1097/COH.0b013e3283582c71. Review.

PMID:
22918448
4.

Emtricitabine/tenofovir disoproxil fumarate: a review of its use in HIV-1 pre-exposure prophylaxis.

Plosker GL.

Drugs. 2013 Mar;73(3):279-91. doi: 10.1007/s40265-013-0024-4. Review.

PMID:
23444256
5.

Animal models of antiretroviral prophylaxis for HIV prevention.

García-Lerma JG, Heneine W.

Curr Opin HIV AIDS. 2012 Nov;7(6):505-13. doi: 10.1097/COH.0b013e328358e484. Review.

PMID:
22964889
6.

Pre-exposure prophylaxis (PrEP) in HIV-uninfected individuals with high-risk behaviour.

Nadery S, Geerlings SE.

Neth J Med. 2013 Jul-Aug;71(6):295-9. Review.

7.

[Pre-exposure prophylaxis for the prevention of sexual HIV transmission; new preventative strategy using tenofovir/emtricitabine].

Boot J, Rump BO, Boucher CA, Op de Coul EL, van Agtmael MA, van de Vijver DA, Burger DM, Fanoy EB.

Ned Tijdschr Geneeskd. 2013;157(27):A6063. Review. Dutch.

PMID:
23838402
8.

The risk of HIV drug resistance following implementation of pre-exposure prophylaxis.

van de Vijver DA, Boucher CA.

Curr Opin Infect Dis. 2010 Dec;23(6):621-7. doi: 10.1097/QCO.0b013e32833ff1e6. Review.

PMID:
20847692
9.

HIV prevention by oral preexposure prophylaxis.

Heneine W, Kashuba A.

Cold Spring Harb Perspect Med. 2012 Mar;2(3):a007419. doi: 10.1101/cshperspect.a007419. Review.

10.

Tenofovir disoproxil fumarate-emtricitabine coformulation for once-daily dual NRTI backbone.

Muñoz de Benito RM, Arribas López JR.

Expert Rev Anti Infect Ther. 2006 Aug;4(4):523-35. Review.

PMID:
17009933
11.

Emtricitabine/tenofovir disoproxil fumarate.

[No authors listed]

Drugs R D. 2004;5(3):160-1. Review.

PMID:
15139777
12.

Oral pre-exposure prophylaxis for HIV prevention.

García-Lerma JG, Paxton L, Kilmarx PH, Heneine W.

Trends Pharmacol Sci. 2010 Feb;31(2):74-81. doi: 10.1016/j.tips.2009.10.009. Epub 2009 Dec 4. Review.

PMID:
19963288
13.

Oral antiretroviral chemoprophylaxis: current status.

Baeten J, Celum C.

Curr Opin HIV AIDS. 2012 Nov;7(6):514-9. doi: 10.1097/COH.0b013e3283582d30. Review.

14.

Preexposure prophylaxis for HIV prevention: where have we been and where are we going?

Baeten JM, Haberer JE, Liu AY, Sista N.

J Acquir Immune Defic Syndr. 2013 Jul;63 Suppl 2:S122-9. doi: 10.1097/QAI.0b013e3182986f69. Review.

15.

Oral preexposure anti-HIV prophylaxis for high-risk U.S. populations: current considerations in light of new findings.

Myers GM, Mayer KH.

AIDS Patient Care STDS. 2011 Feb;25(2):63-71. doi: 10.1089/apc.2010.0222. Review.

PMID:
21284497
16.

Systemic preexposure prophylaxis for HIV: translating clinical data to clinical practice.

Li J, Dufrene SL, Okulicz JF.

Ann Pharmacother. 2014 Apr;48(4):507-18. doi: 10.1177/1060028014520880. Epub 2014 Jan 28. Review.

PMID:
24473492
17.

Once-daily single-tablet regimens: a long and winding road to excellence in antiretroviral treatment.

Llibre JM, Clotet B.

AIDS Rev. 2012 Jul-Sep;14(3):168-78. Review.

PMID:
22833060
18.

Pharmacological considerations for tenofovir and emtricitabine to prevent HIV infection.

Anderson PL, Kiser JJ, Gardner EM, Rower JE, Meditz A, Grant RM.

J Antimicrob Chemother. 2011 Feb;66(2):240-50. doi: 10.1093/jac/dkq447. Epub 2010 Nov 30. Review.

19.

Antiretroviral-based HIV-1 prevention: antiretroviral treatment and pre-exposure prophylaxis.

Celum C, Baeten JM.

Antivir Ther. 2012;17(8):1483-93. doi: 10.3851/IMP2492. Epub 2012 Dec 7. Review.

20.

Systemic and topical drugs for the prevention of HIV infection: antiretroviral pre-exposure prophylaxis.

Baeten J, Celum C.

Annu Rev Med. 2013;64:219-32. doi: 10.1146/annurev-med-050911-163701. Epub 2012 Sep 27. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk